SOPRANO-CD, NCT05169593: Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy |
|
|
| Recruiting | 4 | 292 | Europe | Biological Drug, Risankizumab, Vedolizumab, Ustekinumab, Infliximab, Adalimumab | Universitaire Ziekenhuizen KU Leuven | Crohn Disease | 10/27 | 10/30 | | |